摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 3-(5-(4-(3-chlorophenyl)piperazin-1-ylsulfonyl)indoline-1-carboxamido)benzoate | 1205555-09-4

中文名称
——
中文别名
——
英文名称
ethyl 3-(5-(4-(3-chlorophenyl)piperazin-1-ylsulfonyl)indoline-1-carboxamido)benzoate
英文别名
Ethyl 3-[[5-[4-(3-chlorophenyl)piperazin-1-yl]sulfonyl-2,3-dihydroindole-1-carbonyl]amino]benzoate
ethyl 3-(5-(4-(3-chlorophenyl)piperazin-1-ylsulfonyl)indoline-1-carboxamido)benzoate化学式
CAS
1205555-09-4
化学式
C28H29ClN4O5S
mdl
——
分子量
569.081
InChiKey
RSJBPFRPKJBGQF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    39
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    108
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • [EN] INDOLINE SCAFFOLD SHP-2 INHIBITORS AND CANCER TREATMENT METHOD<br/>[FR] INHIBITEURS DE SHP-2 À SQUELETTE INDOLINE ET PROCÉDÉ DE TRAITEMENT DU CANCER
    申请人:UNIV SOUTH FLORIDA
    公开号:WO2010011666A2
    公开(公告)日:2010-01-28
    The subject invention concerns methods and compounds for inhibiting Shp2. In one embodiment, a compound of the invention has a chemical structure as shown in formula I or II: wherein X, Y, and Z are independently N or S; R1 is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, any of which can be optionally substituted with one or more of halogen; alkyl; heteroalkyl; -COOH; -C(R3)3, wherein R3 can independently be any of -H or halogen; or -OR4, wherein R4 can be any of H, alkyl. or heteroalkyl; R2 is alkyl, alkylcarbonyl, heteroalkylcarbonyl, aryl, arylcarbonyl, heterocycloalkylcarbonyl, cycloalkylcarbonyl, or -C(O)NR6R7, any of which can be optionally substituted with one or more of halogen; alkyl; heteroalkyl; carbonyl; -OR4, wherein R4 can be -H, alkyl, or heteroalkyl; -OH; -C(RO3)3, wherein R3 can independently be any of -H or halogen; aryl, which can be substituted with one or more of halogen or - OR4; heterocycloalkyl; or -C(O)OR5, wherein R5 can be -H or alkyl; R6 and R7 are independently -H, alkyl, heteroalkyl, aryl, or heteroaryl; and R1 is H or alkyl; or a pharmaceutically acceptable salt or hydrate thereof.
查看更多